SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
cency
Lv4
590 积分
2023-05-15 加入
最近求助
最近应助
互助留言
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors
1个月前
已完结
Cross-Reactivity of Antibodies to Rituximab with Other Therapeutic Anti-CD20 Antibodies
1个月前
已完结
Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome
1个月前
已完结
MTMR3 risk alleles enhance Toll Like Receptor 9-induced IgA immunity in IgA nephropathy
1个月前
已完结
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy
1个月前
已完结
Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy
1个月前
已完结
Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy
1个月前
已完结
Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome
1个月前
已完结
Anti-nephrin antibodies in recurrence of focal segmental glomerulosclerosis: closer to discovering the Holy Grail?
1个月前
已完结
Cross-Reactivity of Antibodies to Rituximab with Other Therapeutic Anti-CD20 Antibodies
1个月前
已完结
没有进行任何应助
感谢
11个月前
感谢!
11个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论